CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-15 | Vitale Nancy Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-04 | PIERCE GLENN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-04 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-04 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-04 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-04 | DIXON WENDY L Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-04 | PAUL STEVEN M Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-04 | LEVIN MARK J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-05-21 | Khwaja Omar | Sale | −3,500 | $12.96 | $45K | 56,500 |
| 2020-04-03 | Hesslein Robert W. Senior VP & General Counsel | Sale | −3,091 | $8.51 | $26K | 52,534 |
| 2020-02-10 | Dorval Allison Chief Financial Officer | Grant or award | +27,500 | 52,022 | ||
| 2020-02-10 | Dorval Allison Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-02-10 | Hesslein Robert W. Senior VP & General Counsel | Grant or award | +27,500 | 55,625 | ||
| 2020-02-10 | Hesslein Robert W. Senior VP & General Counsel | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-02-10 | Khwaja Omar | Grant or award | +30,000 | 60,000 | ||
| 2020-02-10 | Khwaja Omar | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2020-02-10 | Turenne Andre President & CEO | Grant or award | +81,250 | 166,795 | ||
| 2020-02-10 | Turenne Andre President & CEO | Grant or award · Stock Option (Right to Buy) | +162,500 | 162,500 | ||
| 2020-01-21 | Dorval Allison Chief Financial Officer | Sale | −3,128 | $13.36 | $42K | 24,522 |
| 2020-01-21 | Ottmer Matthew P. Chief Operating Officer | Sale | −3,724 | $13.36 | $50K | 26,276 |
Page 13 of 19 · 368 trades